Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
315
days
JAK Inhibitors in Inflammatory Skin Diseases: A 15,427-Patient Systematic Review and Meta-analysis of Clinical Trial and Real-World Outcomes
AuthorsNada Faheem Zayed; Khaled Seetan; Almu’atasim Khamees; Raghad Yousef Yassin; Saleh A. Ba-shammakh
Affiliations1. Faculty of Medicine, Balqa Applied University, Salt, Jordan; 2. Faculty of Medicine, Yarmouk University, Irbid, Jordan; 3. Princess Basma Teaching Hospital, Ministry of Health, Irbid, Jordan; 4. Faculty of Pharmacy, Yarmouk University, Irbid, Jordan
109
days
Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report
AuthorsIbrahim El-Serafi; Rui He; Ying Zhao; Jonas Mattsson; Moustapha Hassan
Affiliations1. Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet-Huddinge, NovumStockholm, Sweden; 2. Basic Medical Sciences Department, College of Medicine, Ajman University, Ajman, UAE; 3. Department of Human Resource, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; 4. Clinical Research Center and Center of Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Huddinge, Sweden; 5. Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada; 6. Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
174
days
Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles
AuthorsClaudia Carmassi; Christoph U. Correll; Javier de Diego-Adeliño; Antonio Vian-Lains; Ciro Oliveira; Alex Schneider-Pérez; Vikas Mohan Sharma
Affiliations1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2. Department of Child and Adolescent Psychiatry, Universitätsmedizin Charité Berlin, Berlin, Germany; 3. Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA; 4. Northwell, New Hyde Park, USA; 5. Psychiatry Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 6. Mental Health Research Group, Institut de Recerca Sant Pau (IR-Sant Pau), Barcelona, Spain; 7. Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; 8. Centro de Investigación Biomédica en Red (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; 9. Highfield Healthcare, Dublin, Ireland; 10. Psychiatric Clinic, Hospital Júlio de Matos (ULS São José), Lisbon, Portugal; 11. Global Medical Affairs Department, Neuraxpharm, Barcelona, Spain
151
days
Assessing the Adverse Events of Roflumilast and Tapinarof Use in Pediatric and Young Adult Patients with Atopic Dermatitis: A Systematic Review
AuthorsAnya Ramsamooj; Bethany M. Joy; Dave D. Manguerra; Valerie A. Gerriets
Affiliations1. College of Medicine, California Northstate University, Elk Grove, USA; 2. Department of Medical Education, University of California, Merced, Merced, USA
259
days
Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18–64 Years in Hong Kong: A Population-Based Cohort Study
AuthorsGeorge N. Okoli; Yun Lin; Peng Wu; Benjamin J. Cowling
Affiliations1. World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong; 2. Department of Family Medicine, University of Michigan, Ann Arbor, USA; 3. Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, New Territories, Hong Kong
428
days
Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms
AuthorsElahe Orak Sarkani; Sarvenaz Parsa; Sanaz Darash; Zahra Monzavi Chaleshtori; Motahareh Taghizadeh; Sheida Yahyazadeh; Omid Vakili
Affiliations1. Student Research Committee, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran; 2. Department of Clinical Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; 3. Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
15
days
Deuruxolitinib: New Approval
AuthorsSimon Fung
Affiliations1. Springer Nature, Auckland, New Zealand
196
days
Efficacy, Safety, Quality of Life, and Adherence of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review
AuthorsJacob Surma; Jenna Currier; David Doyle; Mackenzy Maddock; Garrett Borgman; Cassandra DeGroat; Sierra Demarinis; Natalie Aguilar; Spencer Williams; Patrick Fakhoury; Robert Stachler
Affiliations1. Covenant Healthcare College of Medicine at Central Michigan University, Saginaw, USA; 2. Stachler ENT, West Bloomfield, USA
130
days
Optimizing Amiodarone Maintenance Dose to Minimize N-Desethylamiodarone Accumulation and Pulmonary Toxicity: Insights from Machine Learning and Pharmacokinetic Simulation
AuthorsMinori Teraguchi; Toshiaki Komatsu; Yuto Akamada; Takeru Nabeta; Hidehira Fukaya; Junya Ako; Katsuya Otori
Affiliations1. Department of Pharmacy, Kitasato University Hospital, Sagamihara, Japan; 2. Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan; 3. Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Sagamihara, Japan
344
days
Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants
AuthorsEva-Maria Sunzel; Giulia Ghibellini; Maria Gutierrez; Debra Ruffo; Shailendra Chavan; Nagnath G. Birajdar; Frank Schneider; Pippa Loupe; Mark Forrest Gordon; Laura Rabinovich-Guilatt
Affiliations1. Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, West Chester, USA; 2. Teva Clinics, Miramar, USA; 3. Watson Pharma Pvt. Ltd. Seawoods, Navi-Mumbai, India; 4. Teva Pharmaceutical Industries Ltd, Ratiopharm GmbH, Ulm, Germany; 5. Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, Netanya, Israel
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days